We aimed to test the efficacy of robot-assisted intelligent rehabilitation treatment in patients with alcohol use disorders with a randomized controlled trial. Specifically, the objective of this trial is to determine whether the robot-assisted intelligent rehabilitation treatment plus treatment as usual has greater efficacy than traditional therapy in the treatment of alcohol use disorders.
Based on artificial intelligence technology, face recognition technology, and virtual reality technology to develop an available Robot-assisted rehabilitation intelligent system. Then, using this intelligent system as a new way of Psychotherapy to provide treatment for patients with alcohol use disorders, and compare with traditional treatment to verify the efficacy and safety of the Robot-assisted rehabilitation intelligent system in Chinese patients with alcohol use disorders.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
100
Participants assigned to this condition were offered 10 individual sessions of robot-assisted rehabilitation treatment, delivered by the Robot-assisted rehabilitation intelligent system. The system contains 10 core cognitive-behavioral therapy (CBT) skill topics (such as functional analysis, coping skills training, reviewing practice exercises, and explaining CBT concepts). A robot therapist demonstrates the target CBT skills and assigns homework to participants. The treatment framework is semi-structured through human-computer interaction. The forms of interaction include inquiries, statements, recommendations summaries, and knowledge assessments.
Both groups will receive treatment as usual, including medication, exercise, and psychological education.
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China
RECRUITINGDesire for alcohol
The primary outcome is patients' desire for alcohol,measured by Visual Analogue Scale(VAS).
Time frame: 3 months
Change Readiness and Treatment Eagerness
The secondary outcome includes participants' Change Readiness and Treatment Eagerness, measured by the Stages of Change Readiness and Treatment Eagerness Scale(SOCRATES).
Time frame: 3 months
Impulsiveness
The secondary outcome includes participants' level of impulsiveness, measured by the Barratt Impulsiveness Scale(Barratt).
Time frame: 3 months
Anxiety
The secondary outcome includes the participants' level of anxiety, measured by generalized Anxiety Disorder-7(GAD-7).
Time frame: 3 months
Depression
The secondary outcome includes the participants' level of depression, measured by Patient Health Questionnaire-9(PHQ-9).
Time frame: 3 months
Perception of stress
The secondary outcome includes participants' perception of stress, measured by the Perceived Stress Scale(PSS).
Time frame: 3 months
Sleep Quality
The secondary outcome includes participants' sleep quality, measured by Pittsburgh Sleep Quality Index(PSQI).
Time frame: 3 months
coping style
The secondary outcome includes participants' coping style, measured by Simplified Coping Style Questionnaire(SCSQ).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 3 months
use of alcohol
The secondary outcome includes participants' use of alcohol.
Time frame: 3 months